6699 — Angelalign Technology Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapFalling Star

Annual income statement for Angelalign Technology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	fx Final	fx Final	Final	Final
Revenue
Total Revenue	118	197	189	210	269
Cost of Revenue
Gross Profit	83.3	128	117	131	168
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	91.1	148	157	214	263
Operating Profit	27.2	49.3	31.4	-3.93	6.28
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	27.7	51.5	37.4	8.58	11.7
Provision for Income Taxes
Net Income After Taxes	21.9	44.3	31.7	6.83	10
Minority Interest
Net Income Before Extraordinary Items
Net Income	21.8	44.3	31.8	7.53	12.1
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	21.8	44.3	31.8	7.53	12.1
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.146	0.307	0.188	0.045	0.072
Special Dividends per Share